Abstract

Abstract Background: Male breast cancer (MBC) is a very rare disease. There are ambiguous opinions about treatment outcomes and survival outcome. This study aimed to investigate the incidence and survival outcome of male breast cancer in Korea. Additionally, we evaluated the differences between male and female breast cancer (FBC). Method: We identified 226,612 breast cancer cases diagnosed between 1999 and 2016 in the Korea Central Cancer Registry (KCCR). We retrospectively analyzed the data that patient demographics and clinical information between MBC and FBC. Overall survival (OS) was estimated according to sex, age, histologic type, stage. Results: Of the 226,612 patients, 1,052 had male breast cancer patient and 225,560 had female breast cancer patients. The ratio of male to female was 0.0047. MBC patients were diagnosed the most frequently in those aged 60-69 years. In contrast, FBC was diagnosed the most frequently in those aged 40-49 years (p<.0001). Male patient received less adjuvant therapy than female patients (radiotherapy, MBC vs. FBC = 8% vs. 22%, chemotherapy, 41.9% vs. 55.7%, p<.0001). The 5-years OS rates after the diagnosis of breast cancer were 88.8% for all patients. MBC has a lower 5-years OS rate than FBC (76.2% for men, and 88.9% for women, p<.0001). Both groups showed lower survival in patients aged ≥60 years. The 5-years OS rates of invasive type were 75.8% for men and 89% for women. The OS rate was lower in both groups as the stage increased. Conclusion: We found that there is a difference between MBC and FBC. The survival outcomes in MBC were worse than that of FBC. This study showed the different OS patterns according to the age, histology, and stage. Based on these results, clinicians need to recognize the difference from FBC when treating MBC. Citation Format: Eungyeong Lee, Heein Jo, Jai Hong Han, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Myong Cheol Lim, Young-Joo Won, Eun Sook Lee, Eun Sook Lee. Survival and clinicopathologic characteristics of male breast cancer patients using Korea national cancer incidence database [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P4-17-05.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call